Empagliflozin treatment in patients with GSD Type Ib | Webinar

Background:
Recently two reports have been published about off-label experimental empagliflozin treatment in GSD Ib patients.

When:
15 September 2020 at 16:00-17:30 CEST

Target Audience:
Health care professionals and patients

The Aims of the Webinar are:
1. To inform about the treatment
2. To share experiences
3. To discuss the next steps